Prevalence of cavum septum pellucidum and/or cavum Vergae in brain computed tomographies of Taiwanese

Jiann Jy Chen, Chi Jen Chen, Hsin Feng Chang, Dem Lion Chen, Yung Chu Hsu, Tzu Pu Chang

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Objective: The reported prevalence of cavum septum pellucidum (CSP) and cavum Vergae (CV) in brain computed tomography (CT) is 5.5% in Great Britain and 1.24% in China but unknown in Taiwan. Moreover, CSP and/or CV has generally been thought to decrease as age progresses, but the evidence of actual prevalence at different age levels is still limited in the literature. Methods: A total of 19,031 patients with brain CT at a regional hospital in northern Taiwan from July 2008 to August 2010 were included in this study. Their radiological official reports were retrospectively reviewed to check for CSP and/or CV. An X2 test was used for statistical analysis (α=.05). Results: The prevalence of CSP and/or CV in all brain CT was 0.93% (n = 177), which was lower than that in the Chinese and British studies. Among them, 2.8% (n = 5) had only CSP, 1.7% (n = 3) had only CV, and 95.5% (n = 169) had coexistent CSP and CV. There is a significant difference in prevalence between the age groups (p = .009), and the prevalence is the highest in the group aged 20-29 years (1.56%) and lowest in the group aged above 80. After age 20-29, the prevalence tends to decrease with increasing age. Conclusion: This is not only the first study of CSP and CV in the Taiwanese population but the study population is also larger than those in the literature. The prevalence was found to approximately decrease as age progresses, but would reach the peak in the young adult group rather than the children or adolescent group.

Original languageEnglish
Pages (from-to)49-54
Number of pages6
JournalActa Neurologica Taiwanica
Volume23
Issue number2
Publication statusPublished - Jun 1 2014

Fingerprint

Septum Pellucidum
Tomography
Brain
Taiwan
Population
Young Adult
China
Age Groups

Keywords

  • Cavum septum pellucidum
  • Cavum Vergae

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology
  • Medicine(all)

Cite this

Prevalence of cavum septum pellucidum and/or cavum Vergae in brain computed tomographies of Taiwanese. / Chen, Jiann Jy; Chen, Chi Jen; Chang, Hsin Feng; Chen, Dem Lion; Hsu, Yung Chu; Chang, Tzu Pu.

In: Acta Neurologica Taiwanica, Vol. 23, No. 2, 01.06.2014, p. 49-54.

Research output: Contribution to journalArticle

Chen, Jiann Jy ; Chen, Chi Jen ; Chang, Hsin Feng ; Chen, Dem Lion ; Hsu, Yung Chu ; Chang, Tzu Pu. / Prevalence of cavum septum pellucidum and/or cavum Vergae in brain computed tomographies of Taiwanese. In: Acta Neurologica Taiwanica. 2014 ; Vol. 23, No. 2. pp. 49-54.
@article{7081f33387e244b7a465d5bcc5f8ff36,
title = "Prevalence of cavum septum pellucidum and/or cavum Vergae in brain computed tomographies of Taiwanese",
abstract = "Objective: The reported prevalence of cavum septum pellucidum (CSP) and cavum Vergae (CV) in brain computed tomography (CT) is 5.5{\%} in Great Britain and 1.24{\%} in China but unknown in Taiwan. Moreover, CSP and/or CV has generally been thought to decrease as age progresses, but the evidence of actual prevalence at different age levels is still limited in the literature. Methods: A total of 19,031 patients with brain CT at a regional hospital in northern Taiwan from July 2008 to August 2010 were included in this study. Their radiological official reports were retrospectively reviewed to check for CSP and/or CV. An X2 test was used for statistical analysis (α=.05). Results: The prevalence of CSP and/or CV in all brain CT was 0.93{\%} (n = 177), which was lower than that in the Chinese and British studies. Among them, 2.8{\%} (n = 5) had only CSP, 1.7{\%} (n = 3) had only CV, and 95.5{\%} (n = 169) had coexistent CSP and CV. There is a significant difference in prevalence between the age groups (p = .009), and the prevalence is the highest in the group aged 20-29 years (1.56{\%}) and lowest in the group aged above 80. After age 20-29, the prevalence tends to decrease with increasing age. Conclusion: This is not only the first study of CSP and CV in the Taiwanese population but the study population is also larger than those in the literature. The prevalence was found to approximately decrease as age progresses, but would reach the peak in the young adult group rather than the children or adolescent group.",
keywords = "Cavum septum pellucidum, Cavum Vergae",
author = "Chen, {Jiann Jy} and Chen, {Chi Jen} and Chang, {Hsin Feng} and Chen, {Dem Lion} and Hsu, {Yung Chu} and Chang, {Tzu Pu}",
year = "2014",
month = "6",
day = "1",
language = "English",
volume = "23",
pages = "49--54",
journal = "Acta Neurologica Taiwanica",
issn = "1019-6099",
publisher = "Taiwan Neurological Society",
number = "2",

}

TY - JOUR

T1 - Prevalence of cavum septum pellucidum and/or cavum Vergae in brain computed tomographies of Taiwanese

AU - Chen, Jiann Jy

AU - Chen, Chi Jen

AU - Chang, Hsin Feng

AU - Chen, Dem Lion

AU - Hsu, Yung Chu

AU - Chang, Tzu Pu

PY - 2014/6/1

Y1 - 2014/6/1

N2 - Objective: The reported prevalence of cavum septum pellucidum (CSP) and cavum Vergae (CV) in brain computed tomography (CT) is 5.5% in Great Britain and 1.24% in China but unknown in Taiwan. Moreover, CSP and/or CV has generally been thought to decrease as age progresses, but the evidence of actual prevalence at different age levels is still limited in the literature. Methods: A total of 19,031 patients with brain CT at a regional hospital in northern Taiwan from July 2008 to August 2010 were included in this study. Their radiological official reports were retrospectively reviewed to check for CSP and/or CV. An X2 test was used for statistical analysis (α=.05). Results: The prevalence of CSP and/or CV in all brain CT was 0.93% (n = 177), which was lower than that in the Chinese and British studies. Among them, 2.8% (n = 5) had only CSP, 1.7% (n = 3) had only CV, and 95.5% (n = 169) had coexistent CSP and CV. There is a significant difference in prevalence between the age groups (p = .009), and the prevalence is the highest in the group aged 20-29 years (1.56%) and lowest in the group aged above 80. After age 20-29, the prevalence tends to decrease with increasing age. Conclusion: This is not only the first study of CSP and CV in the Taiwanese population but the study population is also larger than those in the literature. The prevalence was found to approximately decrease as age progresses, but would reach the peak in the young adult group rather than the children or adolescent group.

AB - Objective: The reported prevalence of cavum septum pellucidum (CSP) and cavum Vergae (CV) in brain computed tomography (CT) is 5.5% in Great Britain and 1.24% in China but unknown in Taiwan. Moreover, CSP and/or CV has generally been thought to decrease as age progresses, but the evidence of actual prevalence at different age levels is still limited in the literature. Methods: A total of 19,031 patients with brain CT at a regional hospital in northern Taiwan from July 2008 to August 2010 were included in this study. Their radiological official reports were retrospectively reviewed to check for CSP and/or CV. An X2 test was used for statistical analysis (α=.05). Results: The prevalence of CSP and/or CV in all brain CT was 0.93% (n = 177), which was lower than that in the Chinese and British studies. Among them, 2.8% (n = 5) had only CSP, 1.7% (n = 3) had only CV, and 95.5% (n = 169) had coexistent CSP and CV. There is a significant difference in prevalence between the age groups (p = .009), and the prevalence is the highest in the group aged 20-29 years (1.56%) and lowest in the group aged above 80. After age 20-29, the prevalence tends to decrease with increasing age. Conclusion: This is not only the first study of CSP and CV in the Taiwanese population but the study population is also larger than those in the literature. The prevalence was found to approximately decrease as age progresses, but would reach the peak in the young adult group rather than the children or adolescent group.

KW - Cavum septum pellucidum

KW - Cavum Vergae

UR - http://www.scopus.com/inward/record.url?scp=84907420397&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907420397&partnerID=8YFLogxK

M3 - Article

C2 - 26035920

AN - SCOPUS:84907420397

VL - 23

SP - 49

EP - 54

JO - Acta Neurologica Taiwanica

JF - Acta Neurologica Taiwanica

SN - 1019-6099

IS - 2

ER -